Literature DB >> 32460013

MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.

Eric J Wolf1, Amanda Miles2, Eliza S Lee3, Syed Nabeel-Shah1, Jack F Greenblatt1, Alexander F Palazzo3, Vincent Tropepe4, Andrew Emili5.   

Abstract

The mammalian mRNA nuclear export process is thought to terminate at the cytoplasmic face of the nuclear pore complex through ribonucleoprotein remodeling. We conduct a stringent affinity-purification mass-spectrometry-based screen of the physical interactions of human RNA-binding E3 ubiquitin ligases. The resulting protein-interaction network reveals interactions between the RNA-binding E3 ubiquitin ligase MKRN2 and GLE1, a DEAD-box helicase activator implicated in mRNA export termination. We assess MKRN2 epistasis with GLE1 in a zebrafish model. Morpholino-mediated knockdown or CRISPR/Cas9-based knockout of MKRN2 partially rescue retinal developmental defects seen upon GLE1 depletion, consistent with a functional association between GLE1 and MKRN2. Using ribonomic approaches, we show that MKRN2 binds selectively to the 3' UTR of a diverse subset of mRNAs and that nuclear export of MKRN2-associated mRNAs is enhanced upon knockdown of MKRN2. Taken together, we suggest that MKRN2 interacts with GLE1 to selectively regulate mRNA nuclear export and retinal development.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GLE1; MKRN2; RNA binding proteins; affinity purification mass spectrometry; mRNA export; zebrafish retinogenesis

Mesh:

Substances:

Year:  2020        PMID: 32460013     DOI: 10.1016/j.celrep.2020.107693

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  1 in total

1.  MKRN2 inhibits the proliferation of gastric cancer by downregulating PKM2.

Authors:  Zheng Liu; Shuyao Xiang; Xingchen Guo; Jinghuan Zhou; Lixin Liao; Jiaxin Kou; Jun Zhang
Journal:  Aging (Albany NY)       Date:  2022-02-23       Impact factor: 5.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.